O	O	O	0	10	Activation	Activation	B-NP	NN	O	12	SUB	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	14	17	the	the	B-NP	DT	O	6	NMOD	O
T1	B-Protein	B-Protein	18	29	interleukin	interleukin	I-NP	NN	B-DNA	6	NMOD	B-DNA
T1	I-Protein	I-Protein	30	31	6	6	I-NP	CD	I-DNA	6	NMOD	I-DNA
O	O	O	32	36	gene	gene	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	37	39	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	40	53	Mycobacterium	Mycobacterium	B-NP	NN	O	9	NMOD	O
O	O	O	54	66	tuberculosis	tuberculosis	I-NP	NN	O	11	NMOD	O
O	O	O	67	69	or	or	I-NP	CC	O	11	NMOD	O
O	O	O	70	88	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	7	PMOD	O
O	O	O	89	91	is	be	B-VP	VBZ	O	28	VMOD	O
O	O	O	92	100	mediated	mediate	I-VP	VBN	O	12	VC	O
O	O	O	101	103	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	104	111	nuclear	nuclear	B-NP	JJ	B-protein	19	NMOD	B-protein
O	O	O	112	119	factors	factor	I-NP	NNS	I-protein	19	NMOD	I-protein
T2	B-Protein	B-Protein	120	122	NF	NF	I-NP	NN	I-protein	19	NMOD	I-protein
T2	I-Protein	I-Protein	122	123	-	-	B-NP	HYPH	O	19	NMOD	O
T2	I-Protein	I-Protein	123	126	IL6	IL6	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	127	130	and	and	I-NP	CC	O	24	NMOD	O
T14	B-Entity	B-Entity	131	133	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T14	I-Entity	I-Entity	133	134	-	-	O	HYPH	I-protein	24	NMOD	I-protein
T14	I-Entity	I-Entity	134	139	kappa	kappa	B-NP	NN	I-protein	24	NMOD	I-protein
T14	I-Entity	I-Entity	140	141	B	B	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	142	143	[	[	O	(	O	28	VMOD	O
O	O	O	143	152	published	publish	B-NP	VBN	O	27	NMOD	O
O	O	O	153	160	erratum	erratum	I-NP	NN	O	28	SUB	O
O	O	O	161	168	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	O	169	171	in	in	B-PP	IN	O	28	VMOD	O
O	O	O	172	176	Proc	Proc	B-NP	NNP	O	36	NMOD	O
O	O	O	177	181	Natl	Natl	I-NP	NNP	O	36	NMOD	O
O	O	O	182	186	Acad	Acad	I-NP	NNP	O	36	NMOD	O
O	O	O	187	190	Sci	Sci	I-NP	NNP	O	36	NMOD	O
O	O	O	191	192	U	U	I-NP	NNP	O	36	NMOD	O
O	O	O	193	194	S	S	I-NP	NNP	O	36	NMOD	O
O	O	O	195	196	A	A	I-NP	NNP	O	38	NMOD	O
O	O	O	197	201	1995	1995	I-NP	CD	O	38	NMOD	O
O	O	O	202	205	Apr	Apr	B-PP	IN	O	46	NMOD	O
O	O	O	206	208	11	11	B-NP	CD	O	38	NMOD	O
O	O	O	208	209	;	;	O	:	O	46	P	O
O	O	O	209	211	92	92	B-NP	CD	O	46	NMOD	O
O	O	O	211	212	(	(	O	(	O	46	NMOD	O
O	O	O	212	213	8	8	B-NP	CD	O	46	NMOD	O
O	O	O	213	214	)	)	O	)	O	46	NMOD	O
O	O	O	214	215	:	:	O	:	O	46	P	O
O	O	O	215	219	3632	3632	B-NP	CD	O	29	PMOD	O
O	O	O	219	220	]	]	O	)	O	28	VMOD	O

O	O	O	222	225	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	226	230	host	host	I-NP	NN	O	3	NMOD	O
O	O	O	231	239	response	response	I-NP	NN	O	7	SUB	O
O	O	O	240	242	to	to	B-PP	TO	O	3	NMOD	O
O	O	O	243	256	Mycobacterium	Mycobacterium	B-NP	NN	O	6	NMOD	O
O	O	O	257	269	tuberculosis	tuberculosis	I-NP	NN	O	4	PMOD	O
O	O	O	270	278	includes	include	B-VP	VBZ	O	0	ROOT	O
O	O	O	279	288	granuloma	granuloma	B-NP	NN	O	9	NMOD	O
O	O	O	289	298	formation	formation	I-NP	NN	O	16	NMOD	O
O	O	O	299	301	at	at	B-PP	IN	O	9	NMOD	O
O	O	O	302	307	sites	site	B-NP	NNS	O	10	PMOD	O
O	O	O	308	310	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	311	320	infection	infection	B-NP	NN	O	12	PMOD	O
O	O	O	321	324	and	and	O	CC	O	16	NMOD	O
O	O	O	325	333	systemic	systemic	B-NP	JJ	O	16	NMOD	O
O	O	O	334	342	symptoms	symptom	I-NP	NNS	O	7	OBJ	O
O	O	O	342	343	.	.	O	.	O	7	P	O

O	O	O	344	353	Cytokines	Cytokine	B-NP	NNS	B-protein	2	SUB	B-protein
O	O	O	354	358	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	359	363	been	be	I-VP	VBN	O	2	VC	O
O	O	O	364	374	identified	identify	I-VP	VBN	O	3	VC	O
O	O	O	375	377	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	378	398	immunohistochemistry	immunohistochemistry	B-NP	NN	O	5	PMOD	O
O	O	O	399	401	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	402	412	granulomas	granuloma	B-NP	NNS	O	7	PMOD	O
O	O	O	413	415	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	416	422	animal	animal	B-NP	NN	O	11	NMOD	O
O	O	O	423	429	models	model	I-NP	NNS	O	9	PMOD	O
O	O	O	430	432	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	433	441	bacillus	bacillus	B-NP	JJ	O	20	NMOD	O
O	O	O	442	450	Calmette	Calmette	I-NP	NNP	O	20	NMOD	O
O	O	O	450	451	-	-	O	HYPH	O	20	NMOD	O
O	O	O	451	457	Guerin	Guerin	B-NP	NN	O	20	NMOD	O
O	O	O	458	459	(	(	O	(	O	19	DEP	O
O	O	O	459	462	BCG	BCG	B-NP	NN	O	19	DEP	O
O	O	O	462	463	)	)	O	)	O	16	NMOD	O
O	O	O	464	473	infection	infection	B-NP	NN	O	12	PMOD	O
O	O	O	474	477	and	and	O	CC	O	2	VMOD	O
O	O	O	478	481	are	be	B-VP	VBP	O	2	VMOD	O
O	O	O	482	490	released	release	I-VP	VBN	O	22	VC	O
O	O	O	491	493	by	by	B-PP	IN	O	23	VMOD	O
O	O	O	494	505	mononuclear	mononuclear	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	O	506	516	phagocytes	phagocyte	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	O	517	521	upon	upon	B-PP	IN	O	23	VMOD	O
O	O	O	522	533	stimulation	stimulation	B-NP	NN	O	27	PMOD	O
O	O	O	534	536	by	by	B-PP	IN	O	28	NMOD	O
O	O	O	537	550	mycobacterial	mycobacterial	B-NP	JJ	B-protein	31	NMOD	B-protein
O	O	O	551	559	proteins	protein	I-NP	NNS	I-protein	29	PMOD	I-protein
O	O	O	559	560	.	.	O	.	O	2	P	O

O	O	O	561	563	In	In	B-PP	IN	O	14	VMOD	O
O	O	O	564	568	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	569	575	regard	regard	I-NP	NN	O	1	PMOD	O
O	O	O	575	576	,	,	O	,	O	14	P	O
O	O	O	577	580	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	581	589	cytokine	cytokine	I-NP	NN	B-protein	7	NMOD	B-protein
T3	B-Protein	B-Protein	590	601	interleukin	interleukin	I-NP	NN	B-protein	14	SUB	B-protein
T3	I-Protein	I-Protein	602	603	6	6	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	O	604	605	(	(	O	(	O	13	DEP	O
T4	B-Protein	B-Protein	605	607	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	I-Protein	607	608	-	-	B-NP	HYPH	I-protein	13	DEP	I-protein
T4	I-Protein	I-Protein	608	609	6	6	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	609	610	)	)	O	)	O	7	NMOD	O
O	O	O	611	614	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	615	619	play	play	I-VP	VB	O	14	VC	O
O	O	O	620	621	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	622	626	role	role	I-NP	NN	O	15	OBJ	O
O	O	O	627	629	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	630	633	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	634	642	clinical	clinical	I-NP	JJ	O	21	NMOD	O
O	O	O	643	657	manifestations	manifestation	I-NP	NNS	O	24	NMOD	O
O	O	O	658	661	and	and	O	CC	O	24	NMOD	O
O	O	O	662	674	pathological	pathological	B-NP	JJ	O	24	NMOD	O
O	O	O	675	681	events	event	I-NP	NNS	O	18	PMOD	O
O	O	O	682	684	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	685	697	tuberculosis	tuberculosis	B-NP	NN	O	27	NMOD	O
O	O	O	698	707	infection	infection	I-NP	NN	O	25	PMOD	O
O	O	O	707	708	.	.	O	.	O	14	P	O

O	O	O	709	711	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	712	716	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	717	729	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	O	730	734	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	735	752	lipoarabinomannan	lipoarabinomannan	B-NP	NN	B-protein	25	SUB	B-protein
O	O	O	753	754	(	(	O	(	O	8	DEP	O
O	O	O	754	757	LAM	LAM	B-NP	NN	B-protein	8	DEP	B-protein
O	O	O	757	758	)	)	O	)	O	5	NMOD	O
O	O	O	759	763	from	from	B-PP	IN	O	5	NMOD	O
O	O	O	764	767	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	768	781	mycobacterial	mycobacterial	I-NP	JJ	O	13	NMOD	O
O	O	O	782	786	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	O	787	791	wall	wall	I-NP	NN	O	9	PMOD	O
O	O	O	791	792	,	,	O	,	O	13	P	O
O	O	O	793	798	which	which	B-NP	WDT	O	13	NMOD	O
O	O	O	799	802	was	be	B-VP	VBD	O	15	SBAR	O
O	O	O	803	812	virtually	virtually	B-ADJP	RB	O	16	VMOD	O
O	O	O	813	819	devoid	devoid	I-ADJP	JJ	O	16	PRD	O
O	O	O	820	822	of	of	B-PP	IN	O	18	AMOD	O
O	O	O	823	841	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	19	PMOD	O
O	O	O	842	843	(	(	O	(	O	23	DEP	O
O	O	O	843	846	LPS	LPS	B-NP	NN	O	23	DEP	O
O	O	O	846	847	)	)	O	)	O	20	NMOD	O
O	O	O	847	848	,	,	O	,	O	5	P	O
O	O	O	849	859	stimulated	stimulate	B-VP	VBD	O	4	SBAR	O
O	O	O	860	871	mononuclear	mononuclear	B-NP	JJ	B-cell_type	27	NMOD	B-cell_type
O	O	O	872	882	phagocytes	phagocyte	I-NP	NNS	I-cell_type	29	SUB	I-cell_type
O	O	O	883	885	to	to	B-VP	TO	O	29	VMOD	O
O	O	O	886	893	release	release	I-VP	VB	O	25	VMOD	O
T5	B-Protein	B-Protein	894	896	IL	IL	B-NP	NN	B-protein	31	NMOD	B-protein
T5	I-Protein	I-Protein	896	897	-	-	B-NP	HYPH	I-protein	29	OBJ	I-protein
T5	I-Protein	I-Protein	897	898	6	6	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	O	899	901	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	902	903	a	a	B-NP	DT	O	38	NMOD	O
O	O	O	904	908	dose	dose	I-NP	NN	O	38	NMOD	O
O	O	O	908	909	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	O	909	917	response	response	I-NP	NN	O	38	NMOD	O
O	O	O	918	924	manner	manner	I-NP	NN	O	33	PMOD	O
O	O	O	924	925	.	.	O	.	O	2	P	O

O	O	O	926	929	LAM	LAM	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	930	933	and	and	I-NP	CC	O	3	NMOD	O
O	O	O	934	937	LPS	LPS	I-NP	NN	O	4	SUB	O
O	O	O	938	942	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	943	949	potent	potent	B-NP	JJ	O	6	NMOD	O
O	O	O	950	958	inducers	inducer	I-NP	NNS	O	4	PRD	O
O	O	O	959	961	of	of	B-PP	IN	O	6	NMOD	O
T6	B-Protein	B-Protein	962	964	IL	IL	B-NP	NN	B-DNA	11	NMOD	B-DNA
T6	I-Protein	I-Protein	964	965	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T6	I-Protein	I-Protein	965	966	6	6	I-NP	CD	I-DNA	11	NMOD	I-DNA
O	O	O	967	971	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	972	982	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	O	983	985	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	986	996	peripheral	peripheral	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	O	997	1002	blood	blood	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	O	1003	1012	monocytes	monocyte	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	1012	1013	.	.	O	.	O	4	P	O

O	O	O	1014	1018	Both	Both	O	CC	O	12	NMOD	O
O	O	O	1019	1022	LAM	LAM	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1022	1023	-	-	B-NP	HYPH	O	2	P	O
O	O	O	1024	1027	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	1028	1031	LPS	LPS	I-NP	NN	O	12	NMOD	O
O	O	O	1031	1032	-	-	I-NP	HYPH	O	12	NMOD	O
O	O	O	1032	1041	inducible	inducible	I-NP	JJ	O	12	NMOD	O
T7	B-Protein	B-Protein	1042	1044	IL	IL	I-NP	NN	B-DNA	12	NMOD	B-DNA
T7	I-Protein	I-Protein	1044	1045	-	-	I-NP	HYPH	I-DNA	12	NMOD	I-DNA
T7	I-Protein	I-Protein	1045	1046	6	6	I-NP	CD	I-DNA	12	NMOD	I-DNA
T15	B-Entity	B-Entity	1047	1055	promoter	promoter	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	1056	1064	activity	activity	I-NP	NN	O	13	SUB	O
O	O	O	1065	1068	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1069	1078	localized	localized	B-ADJP	JJ	O	13	PRD	O
O	O	O	1079	1081	to	to	B-PP	TO	O	14	AMOD	O
O	O	O	1082	1083	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	1084	1087	DNA	DNA	I-NP	NN	B-DNA	18	NMOD	B-DNA
O	O	O	1088	1096	fragment	fragment	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	O	1096	1097	,	,	O	,	O	13	P	O
O	O	O	1098	1107	positions	position	B-NP	NNS	O	13	VMOD	O
T16	B-Entity	B-Entity	1108	1109	-	-	O	SYM	B-DNA	20	NMOD	B-DNA
T16	I-Entity	I-Entity	1109	1112	158	158	B-NP	CD	I-DNA	21	PMOD	I-DNA
T16	I-Entity	I-Entity	1113	1115	to	to	B-PP	TO	I-DNA	22	NMOD	I-DNA
T16	I-Entity	I-Entity	1116	1117	-	-	B-NP	SYM	I-DNA	23	PMOD	I-DNA
T16	I-Entity	I-Entity	1117	1119	49	49	I-NP	CD	I-DNA	24	NMOD	I-DNA
O	O	O	1119	1120	,	,	O	,	O	22	P	O
O	O	O	1121	1123	by	by	B-PP	IN	O	22	VMOD	O
O	O	O	1124	1132	deletion	deletion	B-NP	NN	O	29	NMOD	O
O	O	O	1133	1141	analysis	analysis	I-NP	NN	O	33	NMOD	O
O	O	O	1142	1145	and	and	O	CC	O	33	NMOD	O
T8	B-Protein	B-Protein	1146	1161	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	33	NMOD	B-protein
T8	I-Protein	I-Protein	1162	1179	acetyltransferase	acetyltransferase	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	O	1180	1185	assay	assay	I-NP	NN	O	27	PMOD	O
O	O	O	1185	1186	.	.	O	.	O	13	P	O

O	O	O	1187	1190	Two	Two	B-NP	CD	O	6	NMOD	O
O	O	O	1191	1198	nuclear	nuclear	I-NP	JJ	B-protein	4	NMOD	B-protein
O	O	O	1199	1205	factor	factor	I-NP	NN	I-protein	4	NMOD	I-protein
T9	B-Protein	B-Protein	1206	1208	NF	NF	I-NP	NN	I-protein	6	NMOD	I-protein
T9	I-Protein	I-Protein	1208	1209	-	-	B-NP	HYPH	O	6	NMOD	O
T9	I-Protein	I-Protein	1209	1212	IL6	IL6	I-NP	NN	B-protein	37	NMOD	B-protein
O	O	O	1213	1214	(	(	O	(	O	20	DEP	O
T17	B-Entity	B-Entity	1214	1223	positions	position	B-NP	NNS	O	19	NMOD	O
T17	I-Entity	I-Entity	1224	1225	-	-	O	SYM	B-DNA	19	P	B-DNA
T17	I-Entity	I-Entity	1225	1228	153	153	B-NP	CD	I-DNA	19	NMOD	I-DNA
T17	I-Entity	I-Entity	1229	1231	to	to	B-PP	TO	I-DNA	10	NMOD	I-DNA
T17	I-Entity	I-Entity	1232	1233	-	-	B-NP	SYM	I-DNA	11	PMOD	I-DNA
T17	I-Entity	I-Entity	1233	1236	145	145	I-NP	CD	I-DNA	12	NMOD	I-DNA
O	O	O	1237	1240	and	and	O	CC	O	19	NMOD	O
T18	B-Entity	B-Entity	1241	1242	-	-	O	SYM	O	19	VMOD	O
T18	I-Entity	I-Entity	1242	1244	83	83	B-NP	CD	O	19	AMOD	O
T18	I-Entity	I-Entity	1245	1247	to	to	B-PP	TO	O	19	AMOD	O
T18	I-Entity	I-Entity	1248	1249	-	-	B-NP	SYM	O	19	NMOD	O
T18	I-Entity	I-Entity	1249	1251	75	75	I-NP	CD	O	20	DEP	O
O	O	O	1251	1252	)	)	O	)	O	6	NMOD	O
O	O	O	1253	1256	and	and	O	CC	O	37	NMOD	O
O	O	O	1257	1260	one	one	B-NP	CD	O	37	NMOD	O
T19	B-Entity	B-Entity	1261	1268	nuclear	nuclear	I-NP	JJ	B-DNA	37	NMOD	B-DNA
T19	I-Entity	I-Entity	1269	1275	factor	factor	I-NP	NN	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1276	1278	NF	NF	I-NP	NN	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1278	1279	-	-	B-NP	HYPH	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1279	1284	kappa	kappa	I-NP	NN	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1285	1286	B	B	I-NP	NN	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1287	1288	(	(	O	(	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1288	1297	positions	position	B-NP	NNS	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1298	1299	-	-	O	SYM	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1299	1301	72	72	B-NP	CD	I-DNA	35	NMOD	I-DNA
T19	I-Entity	I-Entity	1302	1304	to	to	B-PP	TO	I-DNA	35	NMOD	I-DNA
T19	I-Entity	I-Entity	1305	1306	-	-	B-NP	SYM	I-DNA	35	P	I-DNA
T19	I-Entity	I-Entity	1306	1308	63	63	I-NP	CD	I-DNA	36	DEP	I-DNA
T19	I-Entity	I-Entity	1308	1309	)	)	O	)	I-DNA	37	NMOD	I-DNA
T19	I-Entity	I-Entity	1310	1316	motifs	motif	B-NP	NNS	I-DNA	38	SUB	I-DNA
O	O	O	1317	1320	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1321	1328	present	present	B-ADJP	JJ	O	38	PRD	O
O	O	O	1329	1335	within	within	B-PP	IN	O	39	AMOD	O
O	O	O	1336	1340	this	this	B-NP	DT	O	42	NMOD	O
O	O	O	1341	1349	fragment	fragment	I-NP	NN	O	40	PMOD	O
O	O	O	1349	1350	.	.	O	.	O	38	P	O

O	O	O	1351	1355	Site	Site	B-NP	NN	O	18	SUB	O
O	O	O	1355	1356	-	-	B-PP	HYPH	O	1	NMOD	O
O	O	O	1356	1364	directed	direct	B-NP	VBN	O	4	NMOD	O
O	O	O	1365	1376	mutagenesis	mutagenesis	I-NP	NN	O	2	PMOD	O
O	O	O	1377	1379	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1380	1383	one	one	B-NP	CD	O	5	PMOD	O
O	O	O	1384	1386	or	or	I-NP	CC	O	6	AMOD	O
O	O	O	1387	1391	more	more	I-NP	JJR	O	6	AMOD	O
O	O	O	1392	1394	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1395	1400	these	these	B-NP	DT	O	11	NMOD	O
O	O	O	1401	1407	motifs	motif	I-NP	NNS	O	9	PMOD	O
O	O	O	1408	1414	within	within	B-PP	IN	O	11	NMOD	O
O	O	O	1415	1418	the	the	B-NP	DT	O	17	NMOD	O
T10	B-Protein	B-Protein	1419	1421	IL	IL	I-NP	NN	B-DNA	17	NMOD	B-DNA
T10	I-Protein	I-Protein	1421	1422	-	-	I-NP	HYPH	I-DNA	17	NMOD	I-DNA
T10	I-Protein	I-Protein	1422	1423	6	6	I-NP	CD	I-DNA	17	NMOD	I-DNA
T20	B-Entity	B-Entity	1424	1432	promoter	promoter	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	1433	1445	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1446	1450	that	that	B-SBAR	IN	O	26	DEP	O
O	O	O	1451	1455	each	each	B-NP	DT	O	21	SUB	O
O	O	O	1456	1459	has	have	B-VP	VBZ	O	19	SBAR	O
O	O	O	1460	1468	positive	positive	B-NP	JJ	O	24	NMOD	O
O	O	O	1469	1479	regulatory	regulatory	I-NP	JJ	O	24	NMOD	O
O	O	O	1480	1488	activity	activity	I-NP	NN	O	21	OBJ	O
O	O	O	1489	1492	and	and	O	CC	O	26	DEP	O
O	O	O	1493	1497	that	that	B-SBAR	IN	O	18	VMOD	O
O	O	O	1498	1502	they	they	B-NP	PRP	O	28	NMOD	O
O	O	O	1503	1508	could	could	B-VP	MD	O	26	SBAR	O
O	O	O	1509	1512	act	act	I-VP	VB	O	28	VC	O
O	O	O	1513	1515	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	1516	1517	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	1518	1526	function	function	I-NP	NN	O	38	NMOD	O
O	O	O	1526	1527	-	-	B-NP	HYPH	O	32	P	O
O	O	O	1528	1531	and	and	I-NP	CC	O	38	NMOD	O
O	O	O	1532	1543	orientation	orientation	I-NP	NN	O	38	NMOD	O
O	O	O	1543	1544	-	-	I-NP	HYPH	O	38	NMOD	O
O	O	O	1544	1555	independent	independent	I-NP	JJ	O	38	NMOD	O
O	O	O	1556	1562	manner	manner	I-NP	NN	O	30	PMOD	O
O	O	O	1562	1563	.	.	O	.	O	18	P	O

O	O	O	1564	1572	Deletion	Deletion	B-NP	NN	O	6	SUB	O
O	O	O	1573	1575	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1576	1579	all	all	B-NP	DT	O	5	NMOD	O
O	O	O	1580	1585	three	three	I-NP	CD	O	5	NMOD	O
O	O	O	1586	1594	elements	element	I-NP	NNS	O	2	PMOD	O
O	O	O	1595	1604	abolished	abolish	B-VP	VBD	O	0	ROOT	O
O	O	O	1605	1617	inducibility	inducibility	B-NP	NN	O	6	OBJ	O
O	O	O	1618	1620	of	of	B-PP	IN	O	7	NMOD	O
T11	B-Protein	B-Protein	1621	1623	IL	IL	B-NP	NN	B-DNA	13	NMOD	B-DNA
T11	I-Protein	I-Protein	1623	1624	-	-	B-NP	HYPH	I-DNA	13	P	I-DNA
T11	I-Protein	I-Protein	1624	1625	6	6	I-NP	CD	I-DNA	13	NMOD	I-DNA
T21	B-Entity	B-Entity	1626	1634	promoter	promoter	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	1635	1643	activity	activity	I-NP	NN	O	8	PMOD	O
O	O	O	1644	1646	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	1647	1651	both	both	O	CC	O	18	NMOD	O
O	O	O	1652	1655	LAM	LAM	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1656	1659	and	and	O	CC	O	18	NMOD	O
O	O	O	1660	1663	LPS	LPS	B-NP	NN	O	14	PMOD	O
O	O	O	1663	1664	.	.	O	.	O	6	P	O

O	O	O	1665	1667	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1668	1676	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	O	1677	1681	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	1682	1685	the	the	B-NP	DT	O	13	NMOD	O
T12	B-Protein	B-Protein	1686	1688	NF	NF	I-NP	NN	O	13	NMOD	O
T12	I-Protein	I-Protein	1688	1689	-	-	B-NP	HYPH	O	13	NMOD	O
T12	I-Protein	I-Protein	1689	1692	IL6	IL6	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1693	1696	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	1697	1699	NF	NF	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1699	1700	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	1700	1705	kappa	kappa	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	1706	1707	B	B	I-NP	NN	I-DNA	13	NMOD	I-DNA
T22	B-Entity	B-Entity	1708	1713	sites	site	I-NP	NNS	I-DNA	14	SUB	I-DNA
O	O	O	1714	1721	mediate	mediate	B-VP	VBP	O	3	SBAR	O
T13	B-Protein	B-Protein	1722	1724	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T13	I-Protein	I-Protein	1724	1725	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T13	I-Protein	I-Protein	1725	1726	6	6	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	1727	1736	induction	induction	I-NP	NN	O	14	OBJ	O
O	O	O	1737	1739	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	1740	1748	response	response	I-PP	NN	O	19	PMOD	O
O	O	O	1749	1751	to	to	I-PP	TO	O	20	NMOD	O
O	O	O	1752	1756	both	both	O	CC	O	25	NMOD	O
O	O	O	1757	1760	LPS	LPS	B-NP	NN	O	25	NMOD	O
O	O	O	1761	1764	and	and	I-NP	CC	O	25	NMOD	O
O	O	O	1765	1768	LAM	LAM	I-NP	NN	B-protein	21	PMOD	B-protein
O	O	O	1768	1769	,	,	O	,	O	14	P	O
O	O	O	1770	1776	acting	act	B-VP	VBG	O	14	VMOD	O
O	O	O	1777	1779	as	as	B-PP	IN	O	27	VMOD	O
O	O	O	1780	1789	bacterial	bacterial	B-NP	JJ	B-DNA	33	NMOD	B-DNA
O	O	O	1790	1792	or	or	I-NP	CC	I-DNA	33	NMOD	I-DNA
O	O	O	1793	1806	mycobacterial	mycobacterial	I-NP	JJ	I-DNA	33	NMOD	I-DNA
T23	B-Entity	B-Entity	1807	1815	response	response	I-NP	NN	I-DNA	33	NMOD	I-DNA
T23	I-Entity	I-Entity	1816	1824	elements	element	I-NP	NNS	I-DNA	28	PMOD	I-DNA
O	O	O	1824	1825	.	.	O	.	O	2	P	O
